We are live on
!
Find out more
DCM
DAFNA Capital Management Portfolio holdings
AUM
$440M
1-Year Est. Return
109.12%
This Fund
S&P 500
This Quarter
Est. Return
+11.1%
1 Year Est. Return
+109.12%
3 Year Est. Return
+239.59%
5 Year Est. Return
+227.89%
10 Year Est. Return
+3,611.91%
AUM
$440M
AUM Growth
+$9.07M
(+2.1%)
Cap. Flow
-$6.96M
Cap. Flow
% of AUM
-1.58%
Top 10 Holdings %
Top 10 Hldgs %
52.42%
Holding
87
New
10
Increased
20
Reduced
29
Closed
4
Top Buys
| 1 |
CMPS
Compass Pathways
CMPS
|
+$10.8M |
| 2 |
Nektar Therapeutics
NKTR
|
+$5.13M |
| 3 |
Larimar Therapeutics
LRMR
|
+$4.36M |
| 4 |
BCAX
Bicara Therapeutics
BCAX
|
+$2.76M |
| 5 |
Fulcrum Therapeutics
FULC
|
+$1.9M |
Top Sells
| 1 |
Cytokinetics
CYTK
|
+$9.76M |
| 2 |
Axogen
AXGN
|
+$7.38M |
| 3 |
ATXS
Astria Therapeutics
ATXS
|
+$3.99M |
| 4 |
Revolution Medicines
RVMD
|
+$2.41M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$2.25M |
Sector Composition
| 1 | Healthcare | 87.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
MediWound
MDWD
$181M
| $1.52M | 0.35% |
94,405
-19,207
| -17% | -$334K |
|
52
OrthoPediatrics
KIDS
$507M
| $1.52M | 0.35% |
+95,659
| New | +$1.67M |
|
53
Ultragenyx Pharmaceutical
RARE
$3.12B
| $1.28M | 0.29% |
61,100
+45,100
| +282% | +$1.02M |
|
54
enGene Therapeutics
ENGN
$129M
| $1.28M | 0.29% |
187,353
+23,708
| +14% | +$211K |
|
55
Neurogene
NGNE
$794M
| $1.14M | 0.26% |
56,635
+28,661
| +102% | +$555K |
|
56
ARS Pharmaceuticals
SPRY
$741M
| $1.12M | 0.25% |
139,285
-50,780
| -27% | -$487K |
|
57
CytomX Therapeutics
CTMX
$797M
| $1.08M | 0.25% |
+230,000
| New | +$1.17M |
|
|
MAZE
58
Maze Therapeutics
MAZE
$1.62B
| $1.04M | 0.24% |
+35,000
| New | +$1.54M |
|
59
Mineralys Therapeutics
MLYS
$2.39B
| $1.04M | 0.24% |
38,490
| – | – |
|
60
SCYNEXIS
SCYX
$48.1M
| $997K | 0.23% |
+135,870
| New | +$840K |
|
61
Oric Pharmaceuticals
ORIC
$1.16B
| $945K | 0.22% |
98,724
-42,321
| -30% | -$480K |
|
62
Inspire Medical Systems
INSP
$1.48B
| $939K | 0.21% |
18,200
+9,600
| +112% | +$672K |
|
63
PolyPid
PYPD
$101M
| $911K | 0.21% |
207,900
| – | – |
|
64
TELA Bio
TELA
$35M
| $893K | 0.2% |
1,441,029
| – | – |
|
|
ZBIO
65
Zenas BioPharma
ZBIO
$1.8B
| $831K | 0.19% |
+42,500
| New | +$954K |
|
66
Verrica Pharmaceuticals
VRCA
$98.4M
| $813K | 0.19% |
153,712
-19,739
| -11% | -$126K |
|
67
Fate Therapeutics
FATE
$350M
| $660K | 0.15% |
550,000
| – | – |
|
68
Annexon
ANNX
$975M
| $653K | 0.15% |
117,812
-155,000
| -57% | -$873K |
|
69
Accuray
ARAY
$32.5M
| $652K | 0.15% |
1,680,508
+285,000
| +20% | +$176K |
|
70
NewAmsterdam Pharma
NAMS
$3.79B
| $640K | 0.15% |
+20,000
| New | +$651K |
|
71
Adicet Bio
ACET
$81.1M
| $639K | 0.15% |
93,812
| – | – |
|
72
BioNTech
BNTX
$23.1B
| $622K | 0.14% |
7,000
| – | – |
|
73
Pliant Therapeutics
PLRX
$69.4M
| $614K | 0.14% |
+487,000
| New | +$615K |
|
74
Compugen
CGEN
$224M
| $549K | 0.12% |
257,783
-14,619
| -5% | -$28.4K |
|
75
Orchestra BioMed
OBIO
$220M
| $539K | 0.12% |
126,841
| – | – |
|
Similar funds
FGWP
STCG
SCP
CAAM
AWM
HCM
CPW
DWML